Laboratory of Neurogenetics, National Institute on Aging, National Institutes of Health, Bethesda, Maryland, USA.
Data Tecnica International, Glen Echo, Maryland, USA.
Mov Disord. 2021 Jan;36(1):106-117. doi: 10.1002/mds.28312. Epub 2020 Oct 1.
Previous studies reported various symptoms of Parkinson's disease (PD) associated with sex. Some were conflicting or confirmed in only one study.
We examined sex associations to PD phenotypes cross-sectionally and longitudinally in large-scale data.
We tested 40 clinical phenotypes, using longitudinal, clinic-based patient cohorts, consisting of 5946 patients, with a median follow-up of 3.1 years. For continuous outcomes, we used linear regressions at baseline to test sex-associated differences in presentation, and linear mixed-effects models to test sex-associated differences in progression. For binomial outcomes, we used logistic regression models at baseline and Cox regression models for survival analyses. We adjusted for age, disease duration, and medication use. In the secondary analyses, data from 17 719 PD patients and 7588 non-PD participants from an online-only, self-assessment PD cohort were cross-sectionally evaluated to determine whether the sex-associated differences identified in the primary analyses were consistent and unique to PD.
Female PD patients had a higher risk of developing dyskinesia early during the follow-up period, with a slower progression in activities of daily living difficulties, and a lower risk of developing cognitive impairments compared with male patients. The findings in the longitudinal, clinic-based cohorts were mostly consistent with the results of the online-only cohort.
We observed sex-associated contributions to PD heterogeneity. These results highlight the necessity of future research to determine the underlying mechanisms and importance of personalized clinical management. © 2020 International Parkinson and Movement Disorder Society.
先前的研究报告了帕金森病(PD)与性别相关的各种症状。其中一些在一项研究中存在冲突或仅得到证实。
我们在大规模数据中横断和纵向检查了与 PD 表型相关的性别关联。
我们使用基于纵向诊所的患者队列(包括 5946 名患者,中位随访时间为 3.1 年)测试了 40 种临床表型。对于连续结果,我们使用线性回归在基线时测试性别在发病表现方面的差异,使用线性混合效应模型测试性别在进展方面的差异。对于二项结果,我们在基线时使用逻辑回归模型,在生存分析中使用 Cox 回归模型。我们调整了年龄、疾病持续时间和药物使用情况。在次要分析中,对来自仅在线、自我评估 PD 队列的 17719 名 PD 患者和 7588 名非 PD 参与者的数据进行了横断面评估,以确定在主要分析中确定的性别相关差异是否与 PD 一致且独特。
女性 PD 患者在随访期间早期发生运动障碍的风险较高,日常生活困难的进展速度较慢,认知障碍的风险较低。纵向诊所队列的研究结果与仅在线队列的结果基本一致。
我们观察到与 PD 异质性相关的性别关联。这些结果强调了未来研究确定潜在机制和个性化临床管理重要性的必要性。© 2020 国际帕金森病和运动障碍学会。